Avanir Pharmaceuticals, Inc

AVANIR Pharmaceuticals (AVANIR) is a pharmaceutical company focused on developing, acquiring and commercializing therapeutic products for the treatment of chronic diseases. The Company's product candidates address therapeutic markets that include the central nervous system, inflammatory diseases and infectious diseases. Its principal product candidate, Zenviatm (dextromethorphan hydrobromide/quinidine sulfate), is in Phase III clinical development for the treatment of pseudobulbar affect (PBA) and diabetic peripheral neuropathic pain (DPN pain). AVANIR's first commercialized product, docosanol ...


There are no scholarships at this time


There are no events at this time

Company Data on Avanir Pharmaceuticals, Inc
provided by Owler


Avanir Pharmaceuticals, Inc is hiring for these positions

Show me: All available jobs